T cell prolymphocytic leukemia (TPLL): Symptoms, diagnosis and treatment
T cell prolymphocytic leukemia (TPLL) is an extremely rare form of leukemia that affects mainly older individuals. Only about 600 people will be diagnosed with it in the U.S. in any given year. So, most physicians have never seen it.
But how does TPLL differ from other types of leukemia? Does it have any distinguishing features? What are its symptoms, and how is it treated? Are there any clinical trials available...
Why getting an accurate lymphoma diagnosis matters
If you or a loved one has been diagnosed with lymphoma, you might think all you need to know is whether it’s Hodgkin or non-Hodgkin. But is...
Rare double-hit leukemia survivor: ‘Go straight to UT MD Anderson’
Normally, leukemia is a disease that strikes old people and babies. So, when I was diagnosed with chronic myeloid leukemia in ...
Astrocytoma survivor: Why I joined a targeted therapy clinical trial at UT MD Anderson
Until Groundhog Day 2018, I’d been living a healthy and normal life in Austin with my wife, Amy, and our two young children. Then one day, I woke up with a really bad headache and wound up in the emergency room with suspected meningitis. A few days later, I learned the true culprit: a type of brain tumor called astrocytoma. That diagnosis turned my whole world upside-down.
I chose UT MD Anderson for my astrocytoma treatment...
Stage IV lung cancer survivor: ‘Go straight to UT MD Anderson’
By the time I was diagnosed with stage IV lung cancer in the fall of 2024, it had spread all ...
How an electrical engineer is making a big impact on cancer research
Xiling Shen, Ph.D., was an electrical engineering professor when a landmark discovery prompted him to shift the focus of his work and dedicate...
Can UV light really be used as a cancer treatment?
Normally, you probably hear health care professionals talk about ultraviolet (UV) light regarding sun safety.
That’s because...
15-year stage IV melanoma survivor: ‘This is the best I’ve felt in years’
Sometimes, when people receive a cancer diagnosis, they start going from one doctor to the next, hoping to hear better news.
Dermatologist: How to deal with targeted therapy-related skin rashes
EGFR inhibitors are a class of targeted therapy used to treat several cancers, including colorectal cancer.
About 80% of patients...
Top 5 MD Anderson abstracts at AACR 2025
The American Association for Cancer Research (AACR) Annual Meeting showcases exciting new cancer therapies that help link translational science...